Dr. Sora Lee, MD

Dr. Lee practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Lee's NPI, 1891939237, was assigned on April 29, 2009. Dr. Lee graduated from George Washington University School of Medicine and Health Sciences in 2007. Dr. Lee holds California license A107136.

Dr. Lee's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Lee's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Lee is also affiliated with Providence Cedars-Sinai Tarzana Medical Center. Dmand AI also links Dr. Lee to 2 more dialysis centers and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Lee is board certified in internal medicine by the American Board of Internal Medicine. Dr. Lee is licensed in California.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts and parathyroid gland disorder among the conditions Dr. Lee treats.

CMS data shows 3,591 Medicare services from Dr. Lee across 9 procedure codes in 2024, for 726 Medicare patients. Medicare paid $337,378 for them.

CMS counts 726 Medicare patients who saw Dr. Lee in 2024. The largest group is 75 to 84, with 256 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 54% are also on Medicaid. Their average risk score is 3.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 71, with 42% women.

In 2024, Dr. Lee wrote 575 Medicare Part D claims for 70 patients. 91% of them were for generic drugs. CMS names the drug for 432 of them, across 25 drugs with 11 or more claims each, at $6,970 in total drug cost. In 2023, CMS named 501 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lee for performance year 2024, reported individually. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth.

Dmand AI links 4 papers to Dr. Lee, published from 2013 to 2018. 2018 was the busiest year, with 2. Dr. Lee's most frequent co-authors are Rodney Stan Anderson, MD, Thomas Markus Fandel, MD and Selma P. Wilson, MD.

CMS Open Payments shows 25 general payments to Dr. Lee from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Pfizer Inc. paid the most, $168.

Dr. Lee graduated from George Washington University School of Medicine and Health Sciences in 2007.

Dr. Lee is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.